New research indicates that patients who stop using popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass at a significantly accelerated pace than those who end traditional diet and exercise regimens.
Findings released in a leading medical journal demonstrates that while overweight individuals often shed substantial amounts of their body weight while using the jabs, the mass returns at an average rate of nearly a kilo each month once they quit.
"People buying these medications must be cognizant of the danger of fast rebound weight gain when the treatment is stopped," stated expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting weight in about one and a half years.
Analyzing Therapies
The research, which looked at dozens of studies involving thousands of participants, contrasted the effects of the injectable medications with other pills.
Scientists note that individuals who lose weight through lifestyle changes alone typically have a slower creep back—perhaps 100 grams monthly—after stopping.
Understanding the Fast Regain
Experts believe the mechanism of the drugs explains the amplified regain.
The injections mimic a natural hormone called GLP-1, which helps regulate appetite.
"Sustained high doses of the hormone concentrations several times higher than normal may cause the system to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," noted Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement results in appetite is unsuppressed, making binge eating far more likely."
A Chronic Condition?
Health authorities suggest the injections for individuals with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians contend that, considering the likelihood of weight regain, the therapy should be considered ongoing.
This opinion is reinforced by pharmaceutical companies, who note that the findings "emphasize the chronic nature of excess weight," comparing it to managing diseases like diabetes.
User Experiences
Users who have discontinued the jabs report a powerful return of cravings.
"It felt as if a switch that goes on and I was suddenly ravenous," recalled one woman.
The struggle is worsened if users have not developed sustainable lifestyle or habit changes during therapy.
Growing Adoption
Figures show that a significant number of people in the UK have tried these injections in the past year, with desire being substantial.
- Use is more common among females compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, clinicians caution that while these medications are potent tools for shedding pounds, they are not a standalone fix and long-term success likely depends on combined lifestyle changes.
